PET-CT systems combine functional and anatomical imaging in a single platform — enabling precise detection, staging, and monitoring of cancer, as well as metabolic studies in cardiology and neurology. By integrating positron emission tomography (PET) with computed tomography (CT), these systems offer a comprehensive view of both molecular activity and structural detail in a single exam.Available in various slice configurations from 16 to 128+, PET-CT systems are optimized for oncology diagnostics, brain function evaluation, and cardiac viability studies. Their hybrid design supports accurate, early disease detection and therapy response assessment in both outpatient and hospital-based settings.All systems are hand-picked from global sources, with a focus on quality, compliance, and long-term performance — available in both new and certified pre-owned configurations.